SCHEMBL6634965

SCHEMBL6634965

COC(=O)CCCCCCc1nc(NCc2ccc(O)c(Cl)c2)c2c(n1)sc1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 1/20 0.40
STAT3 P40763 1/20 0.40
STAT6 P42226 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 1/20 0.36
ESR1 P03372 1/20 0.35
ACHE P22303 1/20 0.35
TRPV1 Q8NER1 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635602 0.99 KDM4E (0.40) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6853056 0.97 KDM4E (0.41) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6636035 0.93 KDM4E (0.42) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6235799 0.91 PDE5A (0.42) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6635468 0.91 HSD17B10 (0.41) STAT6HSD17B10TRPV1
SCHEMBL6238004 0.90 PDE5A (0.42) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6635949 0.90 HSD17B10 (0.41) STAT6HSD17B10TRPV1
SCHEMBL6216556 0.88 PDE5A (0.40) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6860829 0.88 KDM4E (0.51) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL6763361 0.88 PDE5A (0.43) KDM4EALDH1A1HPGDSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189907-B1 THIENOPYRIMIDINES AS PHOSPHODIESTERASE INHIBITORS MERCK PATENT GMBH (DE) 2004-12-22 EP disclosed
US-6787548-B1 CARDIOVASCULAR INSUFFICIENCY AND ERECTILE DYSFUNCTION; 3-(4-(3-CHLORO-4-HYDROXYBENZYLAMINO) BENZO(4,5)THIENO(2,3-D)PYRIMIDIN-2-YL)PROPIONIC ACID MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2004-09-07 US disclosed